Sepid Darman Varna Company was established in 2014 and

started its activity in the field of laboratory services. The CEO of

the company was able to produce a VTM cell and solution

extraction kit in 2019 by setting up a research department and

employing a capable scientific team consisting of professors and

prominent academic scientists. The scientific team went further

and started their research on the gene transfer kit in 2020 and

were able to produce a gene transfer kit called Derma Transfer

gene in 2021, which is still monopolized by the United States, and

in 2022, it was selected as a knowledge-based company by the

Vice President for Science, Technology and Knowledge-based

Economy. The research and development of this kit is for mass

production and to meet domestic needs.